Table 1.
Issue | Lund | Halmstad |
---|---|---|
Cell block preparation of pleural effusions | Washed 1–2 times in CytoLyt®, then PreservCyt® 1–3 days, then Cellient™ cell block | Formalin fixation of centrifuged pellet in cassette (bloody samples first washed ≤3 times in CytoLyt®) |
| ||
Cell block preparation of other cytology | CytoLyt® a few hours, then PreservCyt® 1–3 days, then CellientTM cell block | CytoLyt® 1–24 h, then formalin fixation of centrifuged pellet in cassette (nodal EBUS aspirations first in sodium chloride for less than a few hours) |
| ||
PD-L1 staining | 22C3 (Agilent/pharmDx) | 28–8 (Agilent/pharmDx) |
| ||
Staining platform | Ventana Benchmark Ultra | Dako Autostainer Link 48 |
| ||
Control tissue | Tonsil and placenta (on each slide) | Tonsil, placenta, and either small intestine or appendix (on each slide); separate slide stained with negative control reagent; positive and negative cell lines (in each run) |
| ||
PD-L1 analysis of small specimens | Always performed, biopsy preferred in the clinical setting (parallel staining of cell blocks common in 2017–2019) | Always performed, biopsy preferred in the clinical setting |
| ||
PD-L1 analysis of resected tumors | Sometimes performed but not mandatory | Not applicable (no resections) |
PD-L1, programmed death-ligand 1; NSCLC, non-small cell lung cancer.